Scott J. Diede

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Antoni Ribas, Reinhard Dummer, Igor Puzanov et al. · Cell · 2017 · 1.4K citations · Full text

Tumor Immunology, Anti-pd-1 Immunotherapy, Autoimmune Disease +10

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

Georgina V. Long, Reinhard Dummer, Omid Hamid et al. · The Lancet Oncology · 2019 · 899 citations

Oncology, Pembrolizumab Versus Placebo, Melanoma +9

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

Caroline Robert, Antoni Ribas, Omid Hamid et al. · Journal of Clinical Oncology · 2017 · 477 citations · Full text

Durable Complete Response, Medicine, Melanoma +15

Telomerase-Mediated Telomere Addition In Vivo Requires DNA Primase and DNA Polymerases α and δ

Scott J. Diede, Daniel E. Gottschling · Cell · 1999 · 381 citations · Full text

Genome Instability, Dna Polymerases α, Natural Sciences +7

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren et al. · The Lancet Oncology · 2019 · 324 citations

Interim Analysis, Lymphoid Neoplasia, Surgical Oncology +10